Evaluation of HO-1-u-1 cell line as an in vitro model for sublingual drug delivery involving passive diffusion-Initial validation studies

International Journal of Pharmaceutics

Volumn 334, Issue 1-2, 2007, Pages 27-34

  Wang, Yanfeng ^a   Zuo, Zhong ^a   Lee, Kenneth K H ^a   Chow, Moses S S ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

HO 1 u 1; Permeability; Sublingual; Blocker

Indexed keywords

ACEBUTOLOL; ALPRENOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; LABETALOL; MANNITOL; METOPROLOL TARTRATE; NADOLOL; PROPRANOLOL; TESTOSTERONE; TIMOLOL MALEATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL LINE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; HISTOLOGY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; VALIDATION STUDY;

EID: 33947113036     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.10.012     Document Type: Article

References (21)

1. Anderberg E.K., and Artursson P. Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 82 (1993) 392-398
2. Beckett A.H., and Triggs E.J. Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. J. Pharm. Pharmacol. 19 (1967) 31S-41S
3. Bogaert M.G. Clinical pharmacokinetics of nitrates. Cardiovasc. Drugs Ther. 8 (1994) 693-699
4. Chen L.H., Chetty D.J., and Chien Y.W. A mechanistic analysis to characterize oral mucosal properties. Int. J. Pharm. 184 (1999) 63-72
5. Chetty D.J., Chen L.H., and Chien Y.W. Characterization of captopril sublingual permeation of preferred routes and mechanisms. J. Pharm. Sci. 90 (2001) 1868-1877
6. Jacoben J., van Deurs B., Pedersen M., and Rassing R.M. TR146 cells grown on filter as a model for human buccal epithelium: I. Morphology, growth, barrier properties, and permeability. Int. J. Pharm. 125 (1995) 165-184
7. Jain V., Das S.N., Luthra K., Shukla N.K., and Ralhan R. Differential expression of multidrug resistance gene product, P-glycoprotein, in normal, dysplastic and malignant oral mucosa in India. Int. J. Cancer 74 (1997) 128-133
8. Kurosaki Y., Aya N., Okada Y., Nakayama T., and Kimura T. Studies on drug absorption from oral cavity. I. Physicochemical factors affecting absorption from hamster cheek pouch. J. Pharmacobiol. Dyn. 9 (1986) 287-296
9. Lo Muzio L., Staibano S., Pannone G., Mignogna M.D., Serpico R., Rubini C., Fioroni M., Fanali S., and Piattelli A. The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC. Anticancer Res. 20 (2000) 2891-2897
10. Mahar Doan K.M., Humphreys J.E., Webster L.O., Wring S.A., Shampine L.J., Serabjit-Singh C.J., Adkison K.K., and Polli J.W. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J. Pharmacol. Exp. Ther. 303 (2002) 1029-1037
11. Merrett M.N., Owen R.W., and Jewell D.P. Ileal pouch dialysate is cytotoxic to epithelial cell lines, but not to CaCo-2 monolayers. Eur. J. Gastroenterol. Hepatol. 9 (1997) 1219-1226
12. Meza I., Sabanero M., Stefani E., and Cereijido M. Occluding junctions in MDCK cells: modulation of transepithelial permeability by the cytoskeleton. J. Cell Biochem. 18 (1982) 407-421
13. Miyauchi S., Moroyama T., Sakamoto T., Okamoto T., and Takada T. Establishment of human tumor cell line (Ueda-1) derived from squamous cell carcinoma of the floor of the mouth. Jpn. J. Oral Maxillofac. Surg. 31 (1985) 1347-1351
14. Myoken Y., Moroyama Y., Miyauchi S., Takada K., and Namba M. Monoclonal antibodies against human oral squamous cell carcinoma reacting with keratin proteins. Cancer 60 (1987) 2337-2927
15. Nielsen H.M., and Rassing M.R. TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa. Int. J. Pharm. 194 (2000) 155-167
16. Shojaei A.H. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1 (1998) 15-30
17. Shojaei A.H., Khan M., Lim G., and Khosravan R. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer. Int. J. Pharm. 192 (1999) 139-146
18. Squier C.A., and Hall B.K. In-vitro permeability of porcine oral mucosa after epithelial separation, stripping and hydration. Arch. Oral. Biol. 6 (1985) 485-491
19. Swartzendruber D.C., Manganaro A., Madison K.C., Kremer M., Wertz P.W., and Squier C.A. Organization of the intercellular spaces of porcine epidermal and palatal stratum corneum: a quantitative study employing ruthenium tetroxide. Cell Tissue Res. 279 (1995) 271-276
20. Taub M.E., Kristensen L., and Frokjaer S. Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV. Eur. J. Pharm. Sci. 15 (2002) 331-340
21. Wertz P.W., and Squier C.A. Cellular and molecular basis of barrier function in oral epithelium. Crit. Rev. Ther. Drug Carrier Syst. 8 (1991) 237-269